$12.2 million to fund new Conte Center to study neurosteroids
The National Institute of Mental Health has awarded Washington University School of Medicine a $12.2 million grant to create a center aimed at advancing research into neurosteroids as treatments for depression and other psychiatric disorders.
Creed honored for research involving mood, chronic pain, substance use
Meaghan Creed, assistant professor of anesthesiology at Washington University School of Medicine, received the 2021 Freedman Prize from the Brain & Behavior Research Foundation. The prize recognizes exceptional basic research in mental illness.
Pediatric COVID-19 vaccine trial underway
A pediatric COVID-19 vaccine clinical trial is underway in St. Louis. Led by Washington University School of Medicine, about 140 area children will receive the two-shot Moderna vaccine or a placebo at St. Louis Children’s Hospital as part of a clinical trial involving about 100 medical institutions in the U.S. and Canada.
$35 million to support study of sleep disorder linked to neurodegeneration
Researchers at Washington University School of Medicine, the Mayo Clinic in Rochester, Minn., and The Neuro of McGill University have received a five-year grant expected to total $35.1 million for an extension of a study designed to develop biomarkers that indicate which people with REM sleep behavior disorder will go on to develop neurodegenerative diseases.
NIH awards 4 medical school scientists prestigious ‘high-risk, high-reward’ grants
Four researchers at Washington University School of Medicine have been awarded “high-risk, high-reward” grants from the National Institutes of Health (NIH). The grant program aims to inspire scientific discovery by providing support for highly innovative research. The grant recipients are (from left) Linda J. Richards; Brian J. Laidlaw, Anthony W. Orvedahl and Leonid Shmuylovich.
Holehouse receives NSF grant
Alex Holehouse, assistant professor of biochemistry and molecular biophysics at the School of Medicine, along with researchers at the University of California, Merced, and the University of Wyoming, received a four-year $992,485 grant from the National Science Foundation through the new “Integrative Research in Biology” program.
Schmidt recognized for contributions to neuropathology
Robert Schmidt, MD, PhD, professor of pathology and immunology at Washington University School of Medicine, has received the Meritorious Contributions to Neuropathology Award from the American Association of Neuropathologists.
Diabetes research center receives $4.3 million NIH grant
The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health (NIH), has awarded $4.3 million to renew the Washington University Center for Diabetes Translation Research.
‘Fight or flight’ – unless internal clocks are disrupted, study in mice shows
Neuroscientists in Arts & Sciences discovered that the daily release of hormones depends on the coordinated activity of clocks in two parts of the brain, a finding that could have implications for human diseases.
Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs
A new study from Washington University School of Medicine estimates that 78% to 92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patient’s tumor.
Older Stories